Phase 2 Idiopathic Parkinson´s Disease Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Idiopathic Parkinson´s Disease

Technical University of Munich75 enrolled1 locationNCT05931575

Recruiting

Phase 1Phase 2

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

Parkinson's DiseaseIdiopathic Parkinson´s Disease

Kenai Therapeutics12 enrolled3 locationsNCT07106021